Repros Celllife India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 55.69%
- Profit Growth 76.93%
- Ebitda 8.88%
- Net Worth 29.40%
- Total Assets 9.47%
About Repros Celllife India
Repros Celllife India Private Limited (RCIPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 April 2017 (Seven years and nine months 24 days old ). Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jaya Gomedhikam and Kota Krishna serve as directors at the Company.
Company Details
-
Location
Visakhapatnam, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U93090AP2017PTC105666
-
Company No.
105666
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Apr 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Repros Celllife India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kota Krishna
|
Managing Director | 17-Apr-2017 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Jaya Gomedhikam
|
Director | 17-Apr-2017 | Current |
Financial Performance of Repros Celllife India.
Repros Celllife India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 55.69% increase. The company also saw a substantial improvement in profitability, with a 76.93% increase in profit. The company's net worth Soared by an impressive increase of 29.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Repros Celllife India?
In 2019, Repros Celllife India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Life Fertility And Research Centre Private LimitedJaya Gomedhikam and Kota Krishna are mutual person
-
Reproscientific Media Private Limited
Jaya Gomedhikam and Kota Krishna are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Repros Celllife India?
Unlock and access historical data on people associated with Repros Celllife India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Repros Celllife India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Repros Celllife India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.